Redx Pharma
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $36M
Investors
- 5
About Redx Pharma
Based in the UK, Redx Pharma Limited develops targeted small-molecule medicines for fibrotic disease and cancer. Based in Macclesfield, UK and founded in 2010 by its co-founder Neil Murray, Peter Jackson, Derek Lindsay, Redx Pharma Limited previously known as Redx Pharma Plc, conducts drug discovery and clinical development focused primarily on fibrotic diseases. The company develops small-molecule drug candidates targeting the ROCK pathway and Discoidin Domain Receptors. Redx Pharma researches and develops novel small-molecule medicines for fibrosis and cancer. Its pipeline includes Zelasudil (RXC007) for idiopathic pulmonary fibrosis, RXC008 for Crohn's disease-related fibrosis, and RXC004 for cancer treatment. The company also provides drug discovery, translational science, and clinical development expertise. The company generates revenue through research collaborations, licensing agreements, upfront payments, milestone payments, and potential royalties from pharmaceutical partners.
Who invested in Redx Pharma
5 investors across 1 round
See all investors in Redx Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 27, 2026
Amount
$36M
Investors
Questions about Redx Pharma
Who invested in Redx Pharma?
Redx Pharma has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Redx Pharma raised?
Redx Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Redx Pharma last raise money?
Redx Pharma's most recent round on record is a Series A, in Aug 2026.
What does Redx Pharma do?
Based in the UK, Redx Pharma Limited develops targeted small-molecule medicines for fibrotic disease and cancer.
Where is Redx Pharma headquartered?
Redx Pharma is headquartered in Macclesfield, UK.
Which VCs invest in companies like Redx Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Redx Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Redx Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.